HUTCHISON CHINA MEDITECH LTD's ticker is HCM and the CUSIP is 44842L103. A total of 123 filers reported holding HUTCHISON CHINA MEDITECH LTD in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,689 | +41.2% | 690 | 0.0% | 0.00% | – |
| Q2 2023 | $8,280 | -24.7% | 690 | -18.3% | 0.00% | – |
| Q1 2023 | $11,002 | -70.3% | 845 | -66.3% | 0.00% | – |
| Q4 2022 | $37,024 | +68.3% | 2,505 | +0.4% | 0.00% | – |
| Q3 2022 | $22,000 | -51.1% | 2,495 | -30.4% | 0.00% | – |
| Q2 2022 | $45,000 | -35.7% | 3,587 | -2.7% | 0.00% | – |
| Q1 2022 | $70,000 | +100.0% | 3,687 | +270.9% | 0.00% | – |
| Q4 2021 | $35,000 | -12.5% | 994 | -8.6% | 0.00% | – |
| Q3 2021 | $40,000 | -25.9% | 1,088 | -20.4% | 0.00% | – |
| Q2 2021 | $54,000 | +42.1% | 1,366 | +1.9% | 0.00% | – |
| Q1 2021 | $38,000 | -9.5% | 1,341 | +2.8% | 0.00% | – |
| Q4 2020 | $42,000 | 0.0% | 1,305 | 0.0% | 0.00% | – |
| Q3 2020 | $42,000 | +740.0% | 1,305 | +650.0% | 0.00% | – |
| Q2 2020 | $5,000 | +25.0% | 174 | -21.3% | 0.00% | – |
| Q1 2020 | $4,000 | 0.0% | 221 | +30.8% | 0.00% | – |
| Q4 2019 | $4,000 | – | 169 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zeal Asset Management Ltd | 2,684,118 | $84,523,000 | 16.48% |
| Cederberg Capital Ltd | 3,400,000 | $108,868,000 | 2.00% |
| Capital International Sarl | 570,500 | $18,267,000 | 1.91% |
| AIA Group Ltd | 437,118 | $14,971,000 | 1.72% |
| Capital International, Inc./CA/ | 4,711,405 | $150,859,000 | 1.40% |
| M&G INVESTMENT MANAGEMENT LTD | 3,096,345 | $99,083,000 | 0.62% |
| Bellevue Group AG | 947,674 | $30,345,000 | 0.35% |
| Sands Capital Management | 7,051,916 | $225,802,000 | 0.22% |
| E Fund Management (Hong Kong) Co., Ltd. | 18,836 | $603,000 | 0.21% |
| Hudson Bay Capital Management LP | 1,031,212 | $33,020,000 | 0.18% |